Cite
HARVARD Citation
Haddad, P. et al. (2017). Addition of oxaliplatin to neoadjuvant radiochemotherapy in MRI‐defined T3, T4 or N+ rectal cancer: a randomized clinical trial. Asia-Pacific journal of clinical oncology. 13 (6), pp. 416-422. [Online].